Investor and Media Relations
T: (416) 864-3584
E: ir@dundeecorporation.com Read More
Financial Personal
Dundee Corporation Announces the Sale of 8,000 Shares of TauRx Pharmaceuticals Ltd. for Proceeds of US$1 Million
TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Company” or “Dundee”) announced today that it has sold to a private investor 8,000 of the 1,015,008 shares it holds in TauRX Pharmaceuticals Ltd. (“TauRx”) at a pri